VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202

Go back to VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202
(NASDAQ: VYNE) Delayed: 28.56 --0 (-0%)
Previous Close $28.56    52 Week High
Open $28.56    52 Week Low
Day High $28.56    P/E N/A 
Day Low $28.56    EPS
Volume 6,847,602